Viral [ftcn]    
Elimination [phsf]    
LYMPHOMA, MALIGNANT [neop]    
Patients [podg]    
Hepatitis C [dsyn]    
Purpose [ftcn]    
High Prevalence [qnco]    
LYMPHOMA, MALIGNANT [neop]    
Patients [podg]    
Hepatitis C virus infection [dsyn]    
Reported [inpr]    
Retrospective Study [resa]    
LYMPHOMA, MALIGNANT [neop]    
Relationship [qlco]    
LYMPHOMA, MALIGNANT [neop]    
Viral [ftcn]    
Elimination [phsf]    
Patients [podg]    
HEPATITIS C VIRUS [virs]    
Study [mnob]    
Consecutive [qlco]    
HEPATITIS C VIRUS [virs]    
Infected [fndg]    
Patients [podg]    
NEVER [tmco]    
RECEIVED [qlco]    
Interferon Therapy [topp]    
Consecutive [qlco]    
HEPATITIS C VIRUS [virs]    
Infected [fndg]    
Patients [podg]    
RECEIVED [qlco]    
Interferon Therapy [topp]    
Group [idcn]    
Cumulative [qlco]    
LYMPHOMA, MALIGNANT [neop]    
5th [qnco]    
YEAR [tmco]    
2-3 [resa]    
YEAR [tmco]    
YEAR [tmco]    
Cumulative [qlco]    
LYMPHOMA, MALIGNANT [neop]    
Treated [ftcn]    
Patients [podg]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
5th [qnco]    
YEAR [tmco]    
YEAR [tmco]    
YEAR [tmco]    
Cumulative [qlco]    
LYMPHOMA, MALIGNANT [neop]    
Persistent infection [dsyn]    
5th [qnco]    
YEAR [tmco]    
YEAR [tmco]    
YEAR [tmco]    
LYMPHOMA, MALIGNANT [neop]    
Higher [qlco]    
Patients [podg]    
Persistent infection [dsyn]    
Patients [podg]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
Hazard Ratio [qnco]    
Lymphomagenesis [neop]    
Patients [podg]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
LOWER [spco]    
Patients [podg]    
Persistent infection [dsyn]    
Hazard Ratio [qnco]    
Retrospective Study [resa]    
Annual [tmco]    
LYMPHOMA, MALIGNANT [neop]    
Patients [podg]    
HEPATITIS C VIRUS [virs]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
Induced [ftcn]    
Interferon Therapy [topp]    
LYMPHOMA, MALIGNANT [neop]    
Patients [podg]    
Chronic Hepatitis C virus [dsyn]    
rights [qlco]    
Reserve [acty]    
